Growth Metrics

Quest Diagnostics (DGX) Gross Profit (2016 - 2025)

Historic Gross Profit for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $949.0 million.

  • Quest Diagnostics' Gross Profit rose 1701.6% to $949.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 billion, marking a year-over-year increase of 1572.71%. This contributed to the annual value of $3.2 billion for FY2024, which is 625.61% up from last year.
  • Per Quest Diagnostics' latest filing, its Gross Profit stood at $949.0 million for Q3 2025, which was up 1701.6% from $943.0 million recorded in Q2 2025.
  • In the past 5 years, Quest Diagnostics' Gross Profit registered a high of $1.1 billion during Q3 2021, and its lowest value of $736.0 million during Q4 2023.
  • Over the past 5 years, Quest Diagnostics' median Gross Profit value was $858.0 million (recorded in 2024), while the average stood at $878.6 million.
  • Its Gross Profit has fluctuated over the past 5 years, first surged by 9818.84% in 2021, then plummeted by 2612.09% in 2022.
  • Quarter analysis of 5 years shows Quest Diagnostics' Gross Profit stood at $1.0 billion in 2021, then fell by 26.12% to $758.0 million in 2022, then decreased by 2.9% to $736.0 million in 2023, then increased by 16.58% to $858.0 million in 2024, then increased by 10.61% to $949.0 million in 2025.
  • Its Gross Profit was $949.0 million in Q3 2025, compared to $943.0 million in Q2 2025 and $863.0 million in Q1 2025.